Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

India · Delayed Price · Currency is INR

106.99

-5.20 (-4.63%)

Mar 9, 2026, 3:10 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Manufacturing of Pharmaceuticals Formations,	1.46B	1.52B	1.15B	851.40M	712.18M
Manufacturing of Pharmaceuticals Formations, Growth	-4.33%	32.18%	35.48%	19.55%	67.68%
Total	1.46B	1.52B	1.15B	851.40M	712.18M
Total Growth	-4.33%	32.18%	35.48%	19.55%	67.68%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	720.34M	567.39M	255.45M	269.89M	325.32M
India Growth	26.96%	122.12%	-5.35%	-17.04%	98.06%
Export	729.78M	941.98M	885.09M	547.65M	347.39M
Export Growth	-22.53%	6.43%	61.62%	57.64%	39.16%
Unallocated	8.45M	15.28M	12.97M	33.87M	39.47M
Unallocated Growth	-44.72%	17.88%	-61.72%	-14.19%	264.06%
Total	1.46B	1.52B	1.15B	851.40M	712.18M
Total Growth	-4.33%	32.18%	35.48%	19.55%	67.68%

Source: S&P Global Market Intelligence.